 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Tuberculosis & HIV: Treatment
- A Clinical Overview of Isoniazid (INH, Nydrazid) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health - A Clinical Overview of Rifampin (Rifadin, Rimactane) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health - FDA Issues "Black Box" Warning for Cipro, Similar Drugs (July 9, 2008)
From Project Inform - Mycobacterium Tuberculosis: Treatment in the United States and Other High-Income Nations (2006)
A chapter from Clinical Manual for Management of the HIV-Infected Adult.
From AIDS Education & Training Centers National Resource Center - Tuberculosis Treatment in Resource-Limited Settings (2006)
A chapter from Clinical Manual for Management of the HIV-Infected Adult.
From AIDS Education & Training Centers National Resource Center - Virtual Medicine: Web-Based Record System Proves as Potent as Drugs in Treating Tuberculosis (August 9, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - The Tuberculosis Treatment Pipeline (July 2005)
To read PDF, click here
From Treatment Action Group - Drug Interaction Warning: Saquinavir/Ritonavir and Rifampin (Rifampicin, Rifadin, Rimactane, Rofact) (February 8, 2005)
To read PDF, click here
From U.S. Food and Drug Administration - Mycobacterium tuberculosis Disease (December 17, 2004)
A chapter from "Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents" guidelines.
To read PDF, click here
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention - Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors (January 20, 2004)
To read PDF, click here
From U.S. Centers for Disease Control and Prevention - Tuberculosis Treatment Evolves (October 2003)
New guidelines reflect subtle but important shifts in strategy.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Avoid Rifampin/Pyrazinamide Treatment in TB Patients, CDC Says (August 8, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Treatment of Tuberculosis (June 20, 2003)
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention - Technology Transfer Will Allow Countries to Produce Own TB Drugs (June 5, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Controlling Tuberculosis in India (November 25, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Treatment of Tuberculosis (PDF) (October 2002)
Revised guidelines from the American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society of America.
- New Drugs Sought for Top Killer of Young Women Worldwide (July 31, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Notice to Readers: Acquired Rifamycin Resistance in Persons With Advanced HIV Disease Being Treated for Active Tuberculosis With Intermittent Rifamycin-Based Regimens (March 15, 2002)
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention - Tuberculosis: Guidelines Changed for Latent TB Treatment (September 21, 2001)
To read PDF, click here
In AIDS Treatment News, from AIDS Treatment News - Severe Liver Damage With TB Drugs (May 29, 2001)
From Canadian AIDS Treatment Information Exchange
  |
  |